252 related articles for article (PubMed ID: 23465691)
1. The effect of granulocyte and monocyte adsorptive apheresis on serum cytokine levels in patients with ulcerative colitis.
Toya Y; Chiba T; Mizutani T; Sato K; Kasugai S; Matsuda N; Orikasa S; Shibata S; Abiko Y; Akasaka R; Yokoyama N; Oana S; Hirota S; Endo M; Suzuki K
Cytokine; 2013 Apr; 62(1):146-50. PubMed ID: 23465691
[TBL] [Abstract][Full Text] [Related]
2. Suppression of inflammatory cytokine secretion by granulocyte/monocyte adsorptive apheresis in active ulcerative colitis.
Andoh A; Tsujikawa T; Inatomi O; Deguchi Y; Hata K; Kitoh K; Sasaki M; Mitsuyama K; Fujiyama Y
Ther Apher Dial; 2005 Apr; 9(2):123-7. PubMed ID: 15828923
[TBL] [Abstract][Full Text] [Related]
3. Granulocyte and monocyte adsorption apheresis therapy modulates monocyte-derived dendritic cell function in patients with ulcerative colitis.
Iwakami Y; Sakuraba A; Sato T; Takada Y; Izumiya M; Ichikawa H; Hibi T
Ther Apher Dial; 2009 Apr; 13(2):138-46. PubMed ID: 19379153
[TBL] [Abstract][Full Text] [Related]
4. In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.
Tanaka T; Okanobu H; Yoshimi S; Murakami E; Kogame A; Imagawa H; Numata Y; Kuga Y; Moriya T; Ohya T; Kajiyama G
Dig Liver Dis; 2008 Sep; 40(9):731-6. PubMed ID: 18387860
[TBL] [Abstract][Full Text] [Related]
5. An open-label prospective randomized multicenter study shows very rapid remission of ulcerative colitis by intensive granulocyte and monocyte adsorptive apheresis as compared with routine weekly treatment.
Sakuraba A; Motoya S; Watanabe K; Nishishita M; Kanke K; Matsui T; Suzuki Y; Oshima T; Kunisaki R; Matsumoto T; Hanai H; Fukunaga K; Yoshimura N; Chiba T; Funakoshi S; Aoyama N; Andoh A; Nakase H; Mizuta Y; Suzuki R; Akamatsu T; Iizuka M; Ashida T; Hibi T
Am J Gastroenterol; 2009 Dec; 104(12):2990-5. PubMed ID: 19724269
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of granulocyte and monocyte adsorption apheresis in paediatric inflammatory bowel disease: a prospective pilot study.
Martín de Carpi J; Vilar P; Prieto G; García Novo MD; Ribes C; Varea V
J Pediatr Gastroenterol Nutr; 2008 Apr; 46(4):386-91. PubMed ID: 18367949
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.
Sakata Y; Iwakiri R; Amemori S; Yamaguchi K; Fujise T; Otani H; Shimoda R; Tsunada S; Sakata H; Ikeda Y; Ando T; Nakafusa Y; Fujimoto K
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):629-33. PubMed ID: 18679064
[TBL] [Abstract][Full Text] [Related]
8. Adsorptive granulocyte/monocyte apheresis use in severe ulcerative colitis and determination of changes in plasma cytokines.
Beltrán B; Sáez-González E; Moret I; Díaz-Jaime FC; Alvarez-Sotomayor D; Cerrillo E; Iborra M; Bastida G; Aguas M; Nos P
J Clin Apher; 2018 Feb; 33(1):99-103. PubMed ID: 28485025
[TBL] [Abstract][Full Text] [Related]
9. Effects of preoperative leukocytapheresis on inflammatory cytokines following surgery for ulcerative colitis: a prospective randomized study.
Bamba T; Yamamoto T; Umegae S; Matsumoto K
J Clin Apher; 2014 Apr; 29(2):107-12. PubMed ID: 24000140
[TBL] [Abstract][Full Text] [Related]
10. Relevance of the processed blood volume per granulocyte and monocyte apheresis session to its clinical efficacy in patients with ulcerative colitis.
Kikuyama R; Fukunaga K; Kawai M; Yokoyama Y; Kamikozuru K; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kato K; Kono T; Nogami K; Nagase K; Nakamura S; Takei Y; Miwa H; Matsumoto T
Ther Apher Dial; 2011 Aug; 15(4):360-6. PubMed ID: 21884470
[TBL] [Abstract][Full Text] [Related]
11. Effect of granulocyte and monocyte adsorption apheresis on urinary albumin excretion and plasma endothelin-1 concentration in patients with active ulcerative colitis.
Nakamura T; Kawagoe Y; Matsuda T; Ueda A; Ueda Y; Takahashi Y; Tanaka A; Koide H
Blood Purif; 2004; 22(6):499-504. PubMed ID: 15528877
[TBL] [Abstract][Full Text] [Related]
12. Advantages of fecal lactoferrin measurement during granulocyte and monocyte adsorptive apheresis therapy in ulcerative colitis.
Hashiguchi K; Takeshima F; Akazawa Y; Matsushima K; Minami H; Machida H; Yamaguchi N; Shiozawa K; Ohba K; Ohnita K; Ichikawa T; Isomoto H; Nakao K
Digestion; 2015; 91(3):208-17. PubMed ID: 25823500
[TBL] [Abstract][Full Text] [Related]
13. Serial changes of cytokines in active ulcerative colitis: effects of antibiotic combination therapy.
Sato K; Chiba T; Ohkusa T
Hepatogastroenterology; 2009; 56(93):1016-21. PubMed ID: 19760932
[TBL] [Abstract][Full Text] [Related]
14. Intermittent granulocyte and monocyte apheresis versus mercaptopurine for maintaining remission of ulcerative colitis: a pilot study.
Sakuraba A; Sato T; Morohoshi Y; Matsuoka K; Okamoto S; Inoue N; Takaishi H; Ogata H; Iwao Y; Hibi T
Ther Apher Dial; 2012 Jun; 16(3):213-8. PubMed ID: 22607563
[TBL] [Abstract][Full Text] [Related]
15. Long-term clinical impact of early introduction of granulocyte and monocyte adsorptive apheresis in new onset, moderately active, extensive ulcerative colitis.
Yamamoto T; Umegae S; Matsumoto K
J Crohns Colitis; 2012 Aug; 6(7):750-5. PubMed ID: 22398094
[TBL] [Abstract][Full Text] [Related]
16. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
[TBL] [Abstract][Full Text] [Related]
17. Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8, and expression of Toll-like receptor 2 on granulocytes.
Aoki H; Nakamura K; Yoshimatsu Y; Tsuda Y; Irie M; Fukuda K; Hosoe N; Takada N; Shirai K; Suzuki Y
Dig Dis Sci; 2007 Jun; 52(6):1427-33. PubMed ID: 17394078
[TBL] [Abstract][Full Text] [Related]
18. Immunoregulatory effects of adsorptive granulocyte and monocyte apheresis in patients with drug refractory Crohn's disease.
Nagase K; Fukunaga K; Kashiwamura S; Kono T; Kamikozuru K; Yokoyama Y; Hida N; Ohda Y; Takeda N; Yoshida K; Iimuro M; Kikuyama R; Kato K; Miwa H; Matsumoto T
Ther Apher Dial; 2011 Aug; 15(4):367-73. PubMed ID: 21884471
[TBL] [Abstract][Full Text] [Related]
19. Effect and safety of granulocyte-monocyte adsorption apheresis for patients with ulcerative colitis positive for cytomegalovirus in comparison with immunosuppressants.
Yoshino T; Nakase H; Matsuura M; Matsumura K; Honzawa Y; Fukuchi T; Watanabe K; Murano M; Tsujikawa T; Fukunaga K; Matsumoto T; Chiba T
Digestion; 2011; 84(1):3-9. PubMed ID: 21311190
[TBL] [Abstract][Full Text] [Related]
20. Adsorptive granulocyte and monocyte apheresis versus prednisolone in patients with corticosteroid-dependent moderately severe ulcerative colitis.
Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Kikuch K; Saniabadi AR
Digestion; 2004; 70(1):36-44. PubMed ID: 15297776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
